Related Experiment Videos
Recent advances in cystic fibrosis
1Department of Medical Biochemistry, University of Wales College of Medicine, Heath Park, UK.
Journal of Inherited Metabolic Disease
|January 1, 1988
Summary
Cystic fibrosis causes thick mucus in the lungs and digestive tract due to unknown causes. Research suggests a defect in protein secretion and electrolyte transport may be the underlying issue, offering hope for new cystic fibrosis treatments.
Area of Science:
- Genetics
- Cell Biology
- Physiology
Background:
- Cystic fibrosis is a common, lethal inherited disorder.
- It affects N. European and N. American populations.
- Characterized by abnormally viscous mucous secretions.
Purpose of the Study:
- To investigate the pathophysiological basis of cystic fibrosis.
- To identify the genetic defect causing cystic fibrosis.
- To explore potential therapeutic targets for cystic fibrosis.
Main Methods:
- Molecular genetics studies.
- Biochemical analyses of epithelial cells.
- Physiological assessments of electrolyte transport.
Main Results:
- Advances in molecular genetics and cell studies offer optimism for identifying the defect.
- Current evidence points to altered regulation of protein secretion.
- Electrolyte transport disturbances lead to imbalanced epithelial secretions.
Conclusions:
- The basic defect in cystic fibrosis likely involves dysregulated protein secretion and electrolyte transport.
- Understanding these mechanisms is crucial for developing treatments.
- Pharmacological interventions targeting cellular abnormalities may lead to rational therapies for cystic fibrosis.